Friedreich's Ataxia (FA)
Rare Disease·MeSH: Ataxia
Prevalence
5.0 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| SGT-212 | Solid Biosciences Inc. (SLDB) |
Frequently asked questions
How many drugs are in development for Friedreich's Ataxia (FA)?
BioSniper tracks 1 drug in development for Friedreich's Ataxia (FA) across 1 company.
How many clinical trials target Friedreich's Ataxia (FA)?
There are 1 clinical trial targeting Friedreich's Ataxia (FA) tracked by BioSniper.
What is the prevalence of Friedreich's Ataxia (FA)?
The estimated prevalence of Friedreich's Ataxia (FA) is approximately 5.0 per 100,000 population.
Deep-dive into Friedreich's Ataxia (FA)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis